Sharps Technology Inc. STSS shares are trading higher Thursday after the company signed a $30 million purchase order from Nephron Pharmaceuticals. Sharps said the purchase order represents the first ...

We recently published a list of 10 Most Active US Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Sharps Technology, Inc. (NASDAQ:STSS) stands against ...

Shares of Sharps Technology Inc (NASDAQ:STSS) have surged 130% over the past five trading sessions. The company this week unveiled a strategic plan to raise over $400 million through a private ...

Sharps Technology (NASDAQ:STSS) just reported results for the second quarter of 2024. Sharps Technology reported earnings per share of -10 cents. The company did not report any revenue for the quarter ...

Sharps Technology (NASDAQ:STSS) has secured approval from The Nasdaq Stock Market to maintain its listing on the exchange. At an August hearing, the company’s senior management and outside counsel ...

Sharps Technology (NASDAQ:STSS) has announced an over $400M private offering to support its plans to adopt a Solana-based digital asset treasury strategy. The offering consists of a private investment ...

The company successfully closed a public offering, securing approximately $20.0 million in gross proceeds, which can enhance its financial stability and support growth initiatives. The offering ...

Sharps Technology has commenced its first commercial shipments, marking a key transition to revenue-generating operations. The company has made significant upgrades to its manufacturing facility in ...

Sharps Technology (NASDAQ:STSS) stock is up on Thursday after the medical device company announced a $30 million purchase order for its specialty copolymer prefillable syringes. Sharps Technology says ...